C-reactive protein (CRP), as a biomarker of inflammation [46], is involved in stroke and cognitive impairments [47], and KO phospholipids demonstrated anti-inflammatory responses, lowering CRP levels in human subjects [48,49]. This evidence concerns the gene CRP and Cognitive impairment.